Octreotide Acetate
Listing ID#170524
Model83150-76-9
CategoryChemicals

Octreotide Acetate

Specifications

Brand
NJBN STEROID
Origin
China
Certifications
ISO 9001, KOSHER, SGS
MOQ
2mg
Packaging
2mg/10mg/vial
Price Term
FOB,CIF
Payment Term
T/T,Western Union,MoneyGram, Bitcoin
Supply Ability
1kg
Delivery Time
3-5 days
Request Quote
Quick answer

Octreotide Acetate is a Chemicals product. Key specs — Brand: NJBN STEROID; Origin: China; Certifications: ISO 9001, KOSHER, SGS; MOQ: 2mg.

Product Description

1.Quick Details : Product Name : Octreotide Acetate CAS No. : 83150-76-9 Purity (HPLC) : 98.0%min.

Molecular Formula : C49H66N10O10S2 Molecular Weight : 1019.28 Appearance : White powder Single Impurity (HPLC) : 1.0%max Amino Acid Composition : ±10% of theoretical Peptide Content (N%) : ≥80.0% Water Content(Karl Fischer) : ≤7.0% Acetate Content(HPIC) : ≤12.0% Specific Rotation (20/D) : -45.0~-50.0°(c=0.5 95%HAc) MS (ESI) : Consistent Mass Balance : 95.0~105.0% Grade : Pharmaceutical Grade Storage: Closed, below 2 ~ 8℃ preservation Manufacturer : NJBN STEROIDS Usage : octreotide acetate, as an injectable depot formulation for the treatment of growth hormone producing tumors (acromegaly and gigantism).

2.Description : Octreotide (brand name Sandostatin, Novartis Pharmaceuticals) is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. It was first synthesized in 1979 by the chemist Wilfried Bauer.

3.Application : Octreotide has also been used off-label for the treatment of severe, refractory diarrhea from other causes. It is used in toxicology for the treatment of prolonged recurrent hypoglycemia after sulfonylurea and possibly meglitinides overdose.

It has also been used with varying degrees of success in infants with nesidioblastosis to help decrease insulin hypersecretion.

Octreotide has been used experimentally to treat obesity, particularly obesity caused by lesions in the hunger and satiety centers of the hypothalamus, a region of the brain central to the regulation of food intake and energy expenditure.[4] The circuit begins with an area of the hypothalamus, the arcuate nucleus, that has outputs to the lateral hypothalamus (LH) and ventromedial hypothalamus (VMH), the brain's feeding and satiety centers, respectively.[5][6] The VMH is sometimes injured by ongoing treatment for acute lymphoblastic leukemia (ALL) or surgery or radiation to treat posterior cranial fossa tumors.

Related Products